About this trial
This study aimed to demonstrate the characteristic lipid profile changes in patients with inflammatory bowel disease.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients with inflammatory bowel disease; aged 18-80 years; all cases agreed to participate in the study.
Healthy volunteers who agreed to participate in the study.
Disqualifiers
Patients with severe heart disease; patients with severe kidney disease; patients with low blood pressure; patients with severe infections such as sepsis or pneumonia; patients who have used immunosuppressants such as 6-mercaptopurine, imidazole thiopurine, and cyclosporine within a short period, and women during pregnancy; patients who are post-colon resected; patients who disagreed to participate in the study.
Trial population
Healthy volunteers and patients who have inflammation bowel disease.
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Differential lipid composition between disease and healthy groups
Differences in lipid composition between disease and healthy groups.
Differences in lipid composition between active and remission disease
Differences in lipid composition between active and remission disease
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: